Fidelity Investments’s Passage Bio PASG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,053
Closed -$11.9K 5592
2024
Q4
$11.9K Sell
1,053
-90
-8% -$1.17K ﹤0.01% 4400
2024
Q3
$16K Buy
1,143
+90
+9% +$1.43K ﹤0.01% 4274
2024
Q2
$16.7K Sell
1,053
-1
-0.1% -$24 ﹤0.01% 4139
2024
Q1
$28.4K Sell
1,054
-2,047
-66% -$49.3K ﹤0.01% 3865
2023
Q4
$62.6K Hold
3,101
﹤0.01% 3420
2023
Q3
$40.8K Hold
3,101
﹤0.01% 3456
2023
Q2
$58.4K Buy
3,101
+70
+2% +$1.39K ﹤0.01% 3370
2023
Q1
$58.1K Buy
3,031
+48
+2% +$1.3K ﹤0.01% 3390
2022
Q4
$82.3K Sell
2,983
-50
-2% -$1.26K ﹤0.01% 3278
2022
Q3
$76K Sell
3,033
-5
-0.2% -$197 ﹤0.01% 3344
2022
Q2
$143K Sell
3,038
-15,870
-84% -$741K ﹤0.01% 3215
2022
Q1
$1.17M Sell
18,908
-70,694
-79% -$5.83M ﹤0.01% 2751
2021
Q4
$11.4M Sell
89,602
-192,026
-68% -$31.4M ﹤0.01% 2066
2021
Q3
$56.1M Sell
281,628
-46,537
-14% -$11.1M ﹤0.01% 1364
2021
Q2
$86.9M Sell
328,165
-75,569
-19% -$23.4M 0.01% 1179
2021
Q1
$141M Buy
403,734
+139,829
+53% +$59.7M 0.01% 935
2020
Q4
$135M Buy
263,905
+27,418
+12% +$11M 0.01% 905
2020
Q3
$62M Sell
236,487
-1,935
-0.8% -$666K 0.01% 1110
2020
Q2
$130M Buy
238,422
+81,716
+52% +$36.7M 0.01% 769
2020
Q1
$49.4M Buy
+156,706
New +$49M 0.01% 1034

Other funds holding PASG

Fidelity Investments's PASG Position: Q1 2025 in Review

Fidelity Investments sold out of Passage Bio (PASG) in Q1 2025, closing a stake of 1,053 shares — an estimated $11.9K sold.

Fidelity Investments first reported a position in PASG in Q1 2020 and held it in 20 quarters. The position peaked at $141M in Q1 2021. 41 funds tracked by Wall St. Rank hold PASG as of Q1 2025.

  • Fidelity Investments reported no remaining Passage Bio position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 1,053 Passage Bio shares in Q1 2025, an estimated $11.9K.
  • Fidelity Investments first reported a position in Passage Bio in Q1 2020 and held it in 20 quarters.
  • Fidelity Investments's Passage Bio position peaked at $141M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Passage Bio as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.